Back
Iovance Biotherapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
IOVA
Iovance Biotherapeutics
Last Price:
$3.53
Seasonality Move:
-6.32%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Iovance Biotherapeutics Stock Forecast
-
Is Iovance Biotherapeutics Stock Undervalued?The current Iovance Biotherapeutics [IOVA] share price is $3.54. The Score for IOVA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
IOVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Iovance Biotherapeutics Stock Go Up Next Year?
Data Unavailable
Iovance Biotherapeutics Stock Rating
Data Unavailable
Iovance Biotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
iovance.com
52-Week Data
52-Week High:
15.90
52-Week Low:
3.48
Prediction Charts
Market Cap:
1.2B
Price in USD:
3.54
Volume:
6.1M
Beta:
1.42
Technical Analysis
SMA50:
5.35
SMA100:
7.22
SMA200:
8.24
52-Wk Change:
-76.29%
Stock Predictions
-
Is Iovance Biotherapeutics stock public?Yes, Iovance Biotherapeutics is a publicly traded company.
-
What is the Iovance Biotherapeutics stock quote today?The Iovance Biotherapeutics stock price is 3.54 USD today.
-
How to buy Iovance Biotherapeutics stock online?You can buy Iovance Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-28 | 3.93 | 4.24 | 4.43 | 3.62 |
| Mar-3 | 4.27 | 4.03 | 4.57 | 3.99 |
| Mar-4 | 3.95 | 3.93 | 3.96 | 3.75 |
| Mar-5 | 4.02 | 4.04 | 4.19 | 3.88 |
| Mar-6 | 3.93 | 3.75 | 3.95 | 3.74 |
| Mar-7 | 3.70 | 3.74 | 3.80 | 3.58 |
| Mar-11 | 3.75 | 3.90 | 3.97 | 3.71 |
| Mar-12 | 3.91 | 3.82 | 4.01 | 3.73 |
| Mar-13 | 3.82 | 3.52 | 3.92 | 3.50 |
| Mar-14 | 3.54 | 3.59 | 3.62 | 3.48 |
| Mar-17 | 3.61 | 3.75 | 3.84 | 3.61 |
| Mar-18 | 3.71 | 3.57 | 3.74 | 3.55 |
| Mar-19 | 3.57 | 3.56 | 3.66 | 3.52 |
| Mar-20 | 3.54 | 3.54 | 3.71 | 3.52 |
Iovance Biotherapeutics Earnings
Data Unavailable
Iovance Biotherapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.08 per share, an increase this year of $0.49 per share, and an increase next year of $0.44 per share.
* Iovance Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.